Charles River Laboratorie... (CRL)
NYSE: CRL
· Real-Time Price · USD
156.64
0.84 (0.54%)
At close: Aug 15, 2025, 3:59 PM
156.68
0.03%
After-hours: Aug 15, 2025, 05:29 PM EDT
Charles River Laboratories International Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 |
Cash & Equivalents | 182.82M | 229.36M | 194.61M | 210.17M | 179.54M | 337.37M | 276.77M | 157.17M | 200.44M | 201.59M | 233.91M | 193.7M | 206.12M | 241.87M | 241.21M | 212.54M | 222.97M | 465.41M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 998K | 950K | 1.01M | 1.06M | 1.06M | 1.03M | 1.04M | 1.02M |
Long-Term Investments | 216.07M | 214.03M | 218.35M | 235.99M | 233.32M | 244.71M | 243.81M | 301.85M | 300.28M | 293.79M | 311.6M | 290.1M | 280.16M | 198.26M | 201.35M | 201.19M | 213.76M | 211.28M |
Other Long-Term Assets | 296.46M | 294.1M | 278.23M | 307M | 299.71M | 301.98M | 309.38M | 154.88M | 155.47M | 195.01M | 148.28M | 139.6M | 155.47M | 158.39M | 151.54M | 140.25M | 144.03M | 138.15M |
Receivables | 767.57M | 756.63M | 720.91M | 754.21M | 762.22M | 786.98M | 780.38M | 799.31M | 800.65M | 788.31M | 752.39M | 778.5M | 755.34M | 706.8M | 642.88M | 660.45M | 644.03M | 610.57M |
Inventory | 279.55M | 290.16M | 278.54M | 336.2M | 349.11M | 361.28M | 380.26M | 292.97M | 285.28M | 262.58M | 255.81M | 261.52M | 256.76M | 221.18M | 199.15M | 181.69M | 194.34M | 193.58M |
Other Current Assets | 129.92M | 100.23M | 105.8M | 101.51M | 110.84M | 28.42M | 83.38M | 16.64M | 25.67M | 195.88M | 107.58M | 1.38M | n/a | 413K | 97.31M | 143.83M | n/a | 4.01M |
Total Current Assets | 1.47B | 1.51B | 1.4B | 1.49B | 1.5B | 1.67B | 1.61B | 1.44B | 1.5B | 1.45B | 1.44B | 1.42B | 1.39B | 1.33B | 1.27B | 1.38B | 1.27B | 1.42B |
Property-Plant & Equipment | 1.99B | 1.99B | 2.02B | 2.03B | 2B | 2B | 2.03B | 1.9B | 1.93B | 1.9B | 1.86B | 1.75B | 1.77B | 1.63B | 1.58B | 1.46B | 1.47B | 1.31B |
Goodwill & Intangibles | 3.54B | 3.53B | 3.57B | 3.9B | 3.88B | 3.9B | 3.96B | 3.77B | 3.85B | 3.86B | 3.81B | 3.74B | 3.89B | 3.72B | 3.77B | 3.84B | 3.6B | 2.69B |
Total Long-Term Assets | 6.09B | 6.08B | 6.13B | 6.51B | 6.45B | 6.48B | 6.59B | 6.16B | 6.27B | 6.25B | 6.16B | 5.97B | 6.14B | 5.74B | 5.75B | 5.68B | 5.45B | 4.39B |
Total Assets | 7.56B | 7.58B | 7.53B | 8B | 7.95B | 8.15B | 8.2B | 7.61B | 7.77B | 7.7B | 7.6B | 7.38B | 7.53B | 7.08B | 7.02B | 7.06B | 6.72B | 5.81B |
Account Payables | 145.8M | 149.33M | 140.34M | 135.96M | 133.1M | 129.68M | 168.94M | 136.34M | 140.2M | 120M | 205.91M | 181.63M | 211.38M | 225.98M | 198.13M | 127.91M | 110.93M | 127.13M |
Deferred Revenue | 268.34M | 250.46M | 248.32M | 251.97M | 247.18M | 256.38M | 241.82M | 250.49M | 257.4M | n/a | 264.26M | 328.38M | 242.08M | 292.25M | 219.7M | 270.26M | 231.33M | 249.68M |
Short-Term Debt | n/a | n/a | n/a | n/a | 3.21M | 2.63M | n/a | 797K | 1.19M | 4M | 50.2M | n/a | 95K | 99K | 101K | 105K | 108K | 109K |
Other Current Liabilities | 434.73M | 408.79M | 337.04M | 416.17M | 352.24M | 342.41M | 392.24M | 337.14M | 373.22M | 857.39M | 334.23M | 287M | 294.18M | 304.14M | 307.01M | 338.8M | 290.46M | 244.72M |
Total Current Liabilities | 1.08B | 1.05B | 994.1M | 1.01B | 947.52M | 954.81M | 1.06B | 993.82M | 1.01B | 981.39M | 1.09B | 1.01B | 1.05B | 993.84M | 1.03B | 983.75M | 929.61M | 803.38M |
Long-Term Debt | 2.33B | 2.51B | 2.24B | 2.3B | 2.38B | 2.63B | 3.07B | 2.9B | 3.08B | 3.16B | 2.71B | 3.31B | 2.97B | 2.94B | 2.92B | 3.14B | 2.97B | 2.38B |
Other Long-Term Liabilities | 185.21M | 196.4M | 195.21M | 264.74M | 251.38M | 231.05M | -196.04M | -247.31M | -253.91M | 399.25M | 174.82M | -225.65M | 174.31M | -71.67M | -30.69M | -74.08M | -76.6M | -12.07M |
Total Long-Term Liabilities | 3.08B | 3.29B | 3.03B | 3.16B | 3.23B | 3.49B | 3.48B | 3.26B | 3.46B | 3.56B | 3.49B | 3.7B | 3.79B | 3.41B | 3.4B | 3.61B | 3.44B | 2.79B |
Total Liabilities | 4.16B | 4.34B | 4.02B | 4.18B | 4.18B | 4.45B | 4.54B | 4.26B | 4.47B | 4.54B | 4.58B | 4.71B | 4.84B | 4.4B | 4.43B | 4.59B | 4.37B | 3.59B |
Total Debt | 2.79B | 2.99B | 2.72B | 2.76B | 2.84B | 3.08B | 3.07B | 2.9B | 3.08B | 3.17B | 3.1B | 3.35B | 3.41B | 2.98B | 2.92B | 3.17B | 2.97B | 2.4B |
Common Stock | 513K | 512K | 511K | 517K | 517K | 515K | 513K | 514K | 513K | 512K | 509K | 510K | 510K | 509K | 505K | 506K | 505K | 504K |
Retained Earnings | 1.89B | 1.84B | 1.81B | 2.12B | 2.05B | 1.96B | 1.89B | 1.72B | 1.63B | 1.54B | 1.43B | 1.28B | 1.18B | 1.07B | 980.75M | 878.82M | 775.39M | 686.94M |
Comprehensive Income | -166.47M | -265.25M | -317.35M | -192.87M | -269.71M | -249.92M | -196.43M | -268.07M | -208.27M | -239.12M | -262.06M | -395.61M | -258.56M | -174.93M | -164.74M | -132.78M | -108.02M | -127.02M |
Shareholders Equity | 3.35B | 3.19B | 3.46B | 3.78B | 3.72B | 3.64B | 3.6B | 3.31B | 3.25B | 3.11B | 2.98B | 2.63B | 2.65B | 2.61B | 2.53B | 2.43B | 2.32B | 2.18B |
Total Investments | 216.07M | 214.03M | 218.35M | 235.99M | 233.32M | 244.71M | 243.81M | 301.85M | 300.28M | 293.79M | 311.6M | 291.05M | 281.17M | 199.33M | 202.41M | 202.22M | 214.8M | 212.3M |